Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
A global team of experts has identified a promising new approach to prevent recurrence of bacterial vaginosis (BV), a condition that affects millions of women worldwide. In a phase 1 randomized clinical trial of women in the U.S. and South Africa, researchers found that a short course of a multi-strain probiotic restored protective bacteria to the vagina, significantly reducing disease recurrence. Results from the study, a collaboration between investigators from Mass General Brigham, the Centre for the AIDS Programme of Research in South Africa (CAPRISA), and collaborators ...